BIOA
BioAge Labs, Inc.
NASDAQ · USHealthcareBiotechnology
$22.32-2.15%
Price as of Jul 20, 2026
BIOA capital
BioAge Labs, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.63x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 2.66x
Liquidity & coverage
- Current ratio
- 24.76x
- Quick ratio
- 24.76x
- Cash ratio
- 24.21x
- Interest coverage
- -211.45x
- EBITDA / interest
- -185.47x
- Working capital
- $376.0M
Cash & dividend
- FCF / debt
- -21.97x
- Cash flow / debt
- -21.89x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.